TCF-001 TRACK (Target Rare Cancer Knowledge) Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TCF-001 TRACK (Target Rare Cancer Knowledge) Study — Stella

Recruiting

Back to Rare Cancers trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

TargetCancer Foundation, Cambridge, Massachusetts

Key details

Sponsor

TargetCancer Foundation

Collaborators

Foundation Medicine

Enrollment target

~400 participants

Started

October 2020

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov